Table 1 Baseline characteristics of the study participants
Characteristics | Overall N = 280 | Female N = 146 | Male N = 134 | P |
|---|---|---|---|---|
Age (in years), median (IQR) | 16 (13–18) | 16 (13–18) | 16 (13–18) | 0.99 |
Education level, n (%) | 0.22 | |||
Primary | 61 (21.8) | 27 (18.5) | 35 (26.1) | |
Secondary | 212 (75.7) | 114 (78.1) | 97 (72.4) | |
University | 7 (2.5) | 5 (3.4) | 2 (1.5) | |
Infection mode, n (%) | 0.19 | |||
Perinatal | 250 (89.3) | 127 (87.0) | 123 (91.8) | |
Other a | 30 (10.7) | 19 (13.0) | 11 (8.2) | |
Full disclosure of HIV status, n (%) | 0.70 | |||
Yes | 160 (57.4) | 85 (58.2) | 75 (56.0) | |
No | 120 (42.6) | 61 (41.8) | 59 (44.0) | |
Treatment line, n (%) | 0.99 | |||
On first-line ART | 147 (52.5) | 77 (52.7) | 70 (52.2) | |
On second/third-line ART b | 133 (47.5) | 69 (47.3) | 64 (47.8) | |
Current ART regimen, n (%) | 0.99 | |||
TDF-3TC-EFV | 109 (38.9) | 58 (39.7) | 51 (38.1) | |
ABC-3TC-EFV | 30 (10.7) | 16 (11.0) | 14 (10.4) | |
TDF-3TC-LPV/r | 85 (30.4) | 44 (30.1) | 41 (30.6) | |
ABC-3TC-LPV/r | 30 (10.7) | 15 (10.3) | 15 (11.2) | |
Other c | 26 (9.3) | 13 (8.9) | 13 (9.7) | |
Time since ART initiation (years), Median (IQR) | 9.8 (5.1–12.8) | 9.0 (5.1–12.3) | 10.1 (5.1–12.9) | 0.31 |
Access to VL in the last 12 months, n (%) | 203 (72.5) | 113 (77.4) | 90 (67.2) | 0.06 |